Titan Medical Inc. Corporate Update
June 30 2014 - 7:00AM
Marketwired
Titan Medical Inc. Corporate Update
TORONTO, ONTARIO--(Marketwired - Jun 30, 2014) - Titan Medical
Inc. (the "Company") (TSX-VENTURE:TMD) (OTCQX:TITXF) announced
today that Mr. Joe Talarico, Senior Vice President Business
Development has resigned his position with the Company. We would
like to thank Joe for his contribution to Titan during his four
years with the Company. In the interim John Hargrove, Chairman and
CEO will assume the responsibilities for Business Development.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company
(TSX-VENTURE:TMD) (OTCQX:TITXF) focused on the design and
development of a robotic surgical system for application in
minimally invasive surgery ("MIS"). The Company's robotic surgical
system, currently under development, comprises a surgeon-controlled
robotic platform that includes a 3D vision system and interactive
instruments for performing MIS procedures, and a surgeon
workstation that provides the surgeon with an interface to the
robotic platform for controlling the interactive instruments and
providing a 3D endoscopic view of inside a patient's body during
MIS procedures. The robotic surgical system is being designed to
expand robotic surgery into areas of surgical specialties and
simple and complex procedures that are currently under-serviced,
and to allow surgeons to perform procedures within small to medium
size surgical spaces such as general surgery and cholecystectomy.
For more information, visit the Company's website at
www.titanmedicalinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which
reflect the current expectations of management of the Company's
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
"may", "would", "could", "will", "anticipate", "believe", "plan",
"expect", "intend", "estimate", "potential for" and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the "Risk Factors" section of the Company's Annual
Information Form dated April 4, 2014 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward looking
statements prove incorrect, actual results, performance or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Titan Medical Inc.John T. HargroveChairman and Chief Executive
Officer(416) 548-7522 (ext.
151)john.hargrove@titanmedicalinc.comwww.titanmedicalinc.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2023 to Apr 2024